Good morning and welcome. Thank you for joining the Oaktree Specialty Lending Corporation's First Fiscal Quarter 2021 Conference Call. Today's conference call is being recorded. At this time, all participants are in a listen only mode. But we will be prompted for a question and answer session following the prepared remarks.
Now I would like to introduce Michael Mosticchio of Investor Relations, who will host today's conference. Mr. Mosticchio, you may begin.
Thank you, operator, and welcome to Oaktree Specialty Lending Corporation's 1st fiscal quarter conference call. Our earnings release, which we issued this morning, and the accompanying slide presentation can be accessed on the Investors section of our website at oaktreespecialtylending.com. Our speakers today are Armen Panossian, Chief Executive Officer and Chief Investment Officer Matt Pendo, President and Chief Operating Officer and Mel Carlisle, Chief Financial Officer and Treasurer. We will be happy to take your questions following their prepared remarks. Before we begin, I want to remind you that comments on today's call include forward looking statements reflecting our current views with respect to, among other things, the timing or likelihood of the merger closing, the expected synergies and savings associated with the merger, the ability to realize the anticipated benefits of the merger and our future operating results and financial performance.
Our actual results could differ materially from those implied or expressed in the forward looking statements. Please refer to our SEC filings for a discussion of these factors in further detail. We undertake no duty to update or revise any forward looking statements. I'd also like to remind you that nothing on this call constitutes an offer to sell or a solicitation of an offer to purchase any interest in any Oaktree fund. Investors and others should note that Oaktree Specialty Lending uses the Investors section of its corporate website to announce material information.
The company encourages investors, the media and others to review the information that it shares on its website. With that, I would now like to turn the call over to Matt.
Thank you, Mike, and welcome everyone to our Q1 earnings conference call. We appreciate your interest in and support of OCSL, and we hope everyone listening is well. We are off to an excellent start to fiscal year 2021. OCSL delivered solid results for the quarter with earnings, origination activity and credit quality all strong. We reported NAV per share of $6.85 up 5% from the prior quarter.
This increase reflected both gains from the realization of a non core investment that was previously a non accrual as well as ongoing price recovery in our liquid debt investment, which has continued since the market sell off in March. In fact, as a result of our portfolio's strong credit quality and performance since then, our NAV as of December 31 is 3.6% higher than it was 1 year ago. Adjusted net investment income per share for the quarter was $0.14 as compared with $0.17 for the prior quarter. The decrease was primarily due to lower investment income compared to the previous quarter, where we generated exceptionally strong interest income in the form of make whole interest and OID acceleration from the repayment of our investment in NuStar Logistics. Excluding this amount, which contributed approximately $0.04 to adjusted NII last quarter, earnings would have been up as a result of the portfolio's continued growth and increasing yield.
Based on our consistent performance and our expectations for continued strong earnings, our Board increased our quarterly dividend by 9% to $0.12 per share, the 3rd consecutive quarter with the dividend increase. This amount represents a 26% increase from the dividend level 1 year ago. We had another strong quarter of originations where we originated $286,000,000 of new investment commitments. Of these new commitments, nearly 70% were 1st lien loans and included $181,000,000 in private transactions, dollars 84,000,000 in the new issue primary market and $22,000,000 in secondary market purchases. We received $161,000,000 from paydowns and exits in the quarter, including $23,000,000 from our exit of Admentum, a non core position that was previously a non accrual.
The weighted average yield on our new debt investments in the quarter was 8.7%, which compares favorably to the average yield of 7.8% on investments, which we fully exited. Leverage declined to 0.70x net of cash from 0.74x at September 30, driven primarily by the timing of new investment fundings. Approximately $100,000,000 of 1st quarter originations did not settle in December. If they had settled by quarter end, leverage would have been approximately 0.8x. Most of these investments have been funded in January.
As we actively identify opportunities, we also remain focused on sourcing directly originated private credit opportunities. We have continued to augment our sourcing efforts by making several key hires and our pipeline of private investments is robust. That noted, we are approaching these new investments cautiously given the uncertain economic backdrop and recent exuberance from other market participants that has driven pricing in terms to pre pandemic levels. With that in mind, credit quality remains a top priority and a key component of OCSL's foundation. We had no new non accruals in the quarter and we have only one portfolio company with a fair value of $500,000 on non accrual status, which represents 3 basis points of the total portfolio at fair value.
We continued to make good progress in monetizing non core holdings during the quarter, exiting 2 positions. Non core investments now represent $125,000,000 or only about 8% of the portfolio at fair value. Before I turn it over to Arment, I wanted to update you on the planned merger of OCSL and Oaktree Strategic Income Corporation. As we discussed on our last call, we expect this will create a larger, more scaled BDC with increased trading liquidity, potentially broadening our institutional shareholder base and may improve access to lower cost sources of debt. We also anticipate that it will drive NII accretion over both the near and long term.
We are confident that now is the right time to move forward with this merger. Both portfolios have strong credit quality and our transition out of non core assets that we've been working on since 2017 is nearly complete. The registration statement has been declared effective, the proxy solicitation process has begun and the merger is on track to close by the end of the current quarter, with our shareholders and OCSI shareholders scheduled to vote on the transaction on March 15. We encourage all shareholders to review the proxy materials and vote your shares accordingly. Overall, we are very pleased with our quarterly results and we are confident the scale that OCSL will have post merger will help drive further benefits for our shareholders.
With that, I will now turn the call over to Armin.
Thanks, Matt, and good morning, everyone. The rebound in credit and equity markets that we saw in 2020 has continued into 2021, supported by still vulnerable but improving economic conditions and consumer sentiment, as well as exceptional fiscal and monetary stimulus. The rollout of COVID-nineteen vaccines and commitments by the new administration to accelerate that process provide reasons to believe we are nearing the final stages of this public health crisis, adding to investor confidence. All of that noted, valuations feel elevated and might not necessarily reflect current macro conditions or the prevailing outlook for gradual economic growth this year. The ultimate pace of inoculations remains an uncertainty and projections for GDP growth assume an end to the pandemic in the second half of calendar twenty twenty one.
While hopeful, we are also cautious about assuming too much about the final outcome at this stage. With that sense of caution in mind, we continue to approach new investments defensively. We think it is important to view market exuberance with a critical eye and to avoid perilous investment opportunities. We remain focused on protecting the downside in our investments and seeking appropriate compensation for risks taken. Given Oaktree's scale and resources, we are able to invest across multiple markets with diversified businesses.
This enables us to focus our portfolio on stable and lower risk sectors, notably including those largely unaffected or even positively impacted by COVID. We continue to identify compelling opportunities among life sciences and technology companies that are delivering healthcare solutions or capitalizing on the increased level of digital commerce. We're also seeing more direct lending opportunities in support of leveraged buyouts of businesses that are proving resilient in the face of the pandemic and ones that are not easily underwritten via traditional cash flow based technologies. Finally, as we did last year, we continue to carefully study the rescue lending landscape, an area in which we have found appealing opportunities, including 2 investments that we made in the Q1 that I will discuss in more detail shortly. As Matt noted, we are also exiting positions in which we believe there is limited further upside, including some of our lower yielding broadly syndicated loan positions.
Now turning to the overall portfolio performance. At the end of the Q1, the portfolio was well diversified with $1,700,000,000 at fair value across 115 companies. 86% of the portfolio was invested in senior secured loans. Our median portfolio company EBITDA at December 31 was approximately $123,000,000 larger than the typical middle market company, as we continue to favor larger, more diversified businesses. As always, we remain in close contact with management teams and private equity sponsors, and generally, our portfolio companies have the necessary liquidity to manage through the current environment.
Our strong credit quality reflects this. We have only one investment on non accrual, as Matt noted, and amendments and interest modifications continue to be very low. Turning now to investment activities. During the quarter, we found numerous opportunities in companies with attractive risk reward profiles in defensive sectors as well as unique opportunities requiring specially structured terms. I'd like to take a moment to discuss in more detail a few compelling investments we made in the quarter.
Navisite is a provider of IT application and cloud services to middle market companies in the U. S. With recurring revenue accounting for 3 fourths of its income. The company saw financing in connection with a planned acquisition and Oaktree was a sole provider of a $75,000,000 2nd lien term loan with pricing at LIBOR plus 8.5%. OCSL was allocated $23,000,000 of the loan total.
Landcore is an independent low cost aftermarket services and parts provider for the commercial aerospace sector, working with a diverse base of several 100 airline customers. Due to the pandemic and the grounding of over 50% of the global fleet, airlines are deferred maintenance to preserve liquidity. Landcore sought a loan to bridge from the current challenging environment to what it expects will be a resurgence in needed repairs as airline travel rebounds post pandemic amid pent up demand. Oaktree was the sole provider of a $50,000,000 1st lien incremental term loan with a $30,000,000 1st lien delayed draw term loan able to be drawn by the company through September of this year. The term loan was priced at LIBOR plus 7.5%.
OCSL was allocated $27,000,000 of the loan. LATAM Airlines is one of the world's largest airlines and it is the largest airline in Latin America. The company filed for Chapter 11 bankruptcy protection to restructure its debt and ensure operational continuity as the business adapted to the pandemic. LATAM sought to raise a significant amount of capital as part of its restructuring and this led to an over $800,000,000 total commitment for Milktree. OCSL participated alongside our flagship opportunities funds in this deal, which was attractively structured and priced at LIBOR plus 9.75% on a cash basis or 11% PIK.
OCSL was allocated $16,000,000 of this loan. As Matt noted, our pipeline continues to be robust as we are currently evaluating unique and attractive private investment opportunities across a broad set of industries. Our strong liquidity along with the resources of Oaktree put us in an excellent position to pursue these opportunities now and in what we hope is a stable growth environment as the pandemic subsides. Now, I will turn the call over to Mel to discuss our financial results in more detail.
Thank you, Armin. Good morning, everyone. OCSL generated strong financial results in the Q1. Total investment income was $38,200,000 down from $43,600,000 in the previous quarter. The $5,400,000 decline was due to lower interest income based on lower make whole interest and OID acceleration from loan payoffs as Matt noted earlier.
Net expenses for the Q1 totaled $28,200,000 up $9,100,000 sequentially. The increase was driven by higher accrued Part II incentive fees. This was partially offset by lower Part I incentive fees, mainly due to the decrease in investment income. For the quarter, OCSL reported net investment income of $10,000,000 and adjusted net investment income of $19,600,000 or $0.07 and $0.14 per share respectively. As a reminder, we define adjusted NII as NII excluding capital gains, incentive fees or Part II incentive fees.
During the Q1, OCSL accrued a total of 9,500,000 dollars in Part II incentive fees. This amount was mostly due to $48,000,000 in net unrealized gains in the portfolio during the Q1. It is important to note that while CAF requires us to take unrealized gains into account when accruing Part II incentive fee expense each quarter, OCSL will only pay Part II incentive fees annually and to the extent that it has realized gains that exceed realized and unrealized losses at year end. Turning to credit quality, which continues to be very strong. As Matt noted, at quarter end, we had one investment on non accrual, representing 3 basis points of the total portfolio at fair value, down from 10 basis points in the prior quarter.
The decrease was primarily due to the successful exit of Admintum, where we realized a full par recovery on our debt investment and recorded a total gain of $23,000,000 During the quarter, all of our portfolio companies made their scheduled interest payments and since March, only one company has converted its cash interest payments to PIK. Moving to the balance sheet, during the quarter we funded $242,000,000 of investments and received $161,000,000 in payoffs and exits. Our net leverage ratio decreased to 0.70 times from 0.74 times at September 30, reflecting the increase in NAV. We also had $103,000,000 of unsettled purchases at December 31, most of which have funded in January. Adjusting for this timing difference, net leverage would have been approximately 0.80x@quarterend, however, still just below the low end of our leverage targets range of 0.85x to 1.0x.
As of December 31, total debt outstanding was $700,000,000 and had a weighted average interest rate of 2.7%. Unsecured debt represented 43% of our total debt at quarter end, and our next scheduled maturity is in 2024 when our credit facility comes up for renewal. At quarter end, we had total liquidity of approximately $424,000,000 including $24,000,000 of cash $400,000,000 of undrawn capacity in our revolving credit facility. Unfunded commitments were $198,000,000 with approximately $150,000,000 of this amount eligible to be drawn immediately, as the remaining amount is subject to certain milestones that must be met by portfolio companies. In the Q1, we expanded the capacity of our revolving credit facility by 100,000,000 dollars adding a new lender for $75,000,000 and having an existing lender increase its commitment by $25,000,000 Our total revolver commitment is currently $800,000,000 dollars Importantly, both Moody's and Fitch maintained investment grade ratings on OCSL, with both citing our successful progress to date in exiting non core investments, the strength and quality of Oaktree and our lower leverage relative to peers.
Shifting now to the Kemper joint venture. As of December 31, the JV had $341,000,000 of assets invested in senior secured loans to 56 companies. This compared to $313,000,000 of total assets invested in the same number of companies last quarter. Assets increased quarter over quarter mainly due to the increase in the market value of its investments and net portfolio growth as purchases exceeded sales and repayments. As a result of the underlying portfolio depreciation, OCSL investments in the JV were written up by $8,000,000 or 7% from the prior quarter.
Leverage at the JV was 1.2x@quarterend, down slightly from the September quarter. Now, I will turn the call back to Matt.
Thank you, Amel. While the environment continues to be uncertain, we nonetheless generated strong operating results for the Q1. The defensive repositioning that we have carried out since 2017 has largely been completed and we had a strong quarter of originations. We continue to feel very good about our current holdings. Our overall pipeline of potential transactions remains robust and we expect to continue to identify compelling investment opportunities throughout fiscal 2021.
For the last two quarters, we have generated an improved return on equity compared to prior quarters, which is evidence that our efforts in this area are paying off. And we continue to believe that OCSL is well positioned to deliver a higher return on equity. We remain focused on positioning the portfolio for an improved yield by rotating out of lower yielding investments and into higher yielding proprietary loans. During the quarter, we exited $35,000,000 of these types of investments. And as of quarter end, dollars 113,000,000 of senior secured loans priced at or below LIBOR plus 4 point 5% remained in the portfolio.
Our new investments during the quarter came in at an average yield of 8.7%, so there's continued upside to be realized over time. Another opportunity for us to increase ROE is deploying more leverage at the portfolio level. As Mel mentioned, we are operating below the low end of our long term target of 0.85 to 1x. So we would expect to continue to enhance returns as we make incremental investments and deploy higher leverage. However, we will only grow the portfolio as we find opportunities that are consistent with our investment approach that we believe offer an attractive risk reward.
Finally, the Kemper JV continues to present an opportunity for us to improve returns. As of year end, the JV was levered 1.2x and had $50,000,000 of investment capacity. We believe that disciplined growth of the JV will also be accretive to ROE over time. In conclusion, we are very pleased with our strong Q1 results. We're also looking forward to the pending merger with OCSI as we believe that this combination benefits shareholders of both OCSL and OCSI through scale, portfolio diversity and expected earnings accretion.
We are excited about the future for the combined company and remain optimistic that we will continue to identify new attractive risk adjusted investment opportunities, enabling us to deliver improved returns to our shareholders. Thank you for joining us on today's call and for your continued interest in OCSL. With that, we are happy to take your questions. Operator, please open the lines.
We will now begin the question and answer session. And the first question will come from Devin Ryan of JMP Securities. Please go ahead.
Hey, great. Good morning, everyone. Good morning.
Good morning, Devin.
First question here, just given the overlap between OCSL and the OCSI on the investment side, and expectations that the merger will relatively seamless. It would be great if you could give some additional granularity on expectations for the cadence of investment activity in the coming quarters as you reposition the 2 portfolios. And what I'm trying to get at here is, you hear the comments about very strong pipeline and obviously expectation for investment versus some of the comments around valuation and market exuberance and just trying to think about kind of the push pull in all of that.
Sure. Devin, this is Arvind. So in terms of overlap with OCSI and then the cadence of investing after the merger is closed. So in terms of non overlapping investments that are in OCSI but not in OCSL, it's about 33% of the OCSI portfolio at this point, of which 25 percentage points are actually public securities that can be traded, and about $47 or so 1,000,000 of par value of private positions that will take a little bit of a longer time to rotate. So it's a pretty manageable rotation after the close of the merger that we can effectuate.
We think that we can effectuate a rotation, but that will obviously, as you alluded to, will be predicated on our ability to continue to originate attractive loans. Just maybe we could talk a little bit about the markets. I'm sure others will be asking about what we're seeing in the market these days. And I would say, as you know, in private credit, there it's not like you could pay all of private credit with the same paintbrush. There is middle market sponsor finance in support of LBOs.
There's some mezzanine. Within that, there's 2nd lien. And then more typically of what we like doing are the non sponsor loans that are harder to predict the timing of. They're more structured. They're harder to find.
They are they take longer to execute. And so that's kind of the other side of what we do here. What I would say is that on the sponsor side, especially the more typical 1st lien or unitranche loans, that market is back to pre COVID competitive levels, whereby private equity sponsors are coming to market, they're blasting out pitch decks to a variety of middle market direct lenders. Pricing has taken a little bit of a hit, not as much as one would think, but legal terms are taking a hit in terms of covenant light and other flexibility around covenants and other terms in these credit agreements. So for us, we're finding yet again that we are rejecting a whole lot more of that deal flow, just finding it less interesting than we are committing to it.
And so we're turning over a lot of stones with very few investments. With that said, we will continue to do some middle market sponsor finance, especially with those sponsors that are very close relationships of Oaktree that we think have a operational advantage in particular sectors. We have a few things in the pipeline now already with sponsors that meet that description. And so we expect that we will still originate some deals there, but we are not going to be the typical flow, 1st lien or unitranche lender out there, BDC or otherwise, that is willing to kind of cave on legal terms. In fact, we would be more willing to cave on financial terms than on legal terms just given the background of Oaktree as a downside focused lender.
On the other side of the house, the more sort of opportunistic non sponsor side, as Matt and I mentioned, we've been active over the last several quarters in rescue lending or providing liquidity to sectors and companies that are experiencing some level of dislocation due to COVID. We don't expect for that opportunity to fully go away even with the positive reaction that the market has shown over the last several quarters. But it certainly has declined. The pace of our deal flow has declined. We were engaged with a very large issuer over the last couple of quarters on a rescue loan in partnership with our opportunities funds.
And with the exuberance in the markets, they essentially were able to place a bond several 100 basis points tighter than what we were willing to provide them in the public market. So we recognize that the public markets are taking opportunities from us. But with that said, many industries, many businesses are going to continue to need capital over the next several quarters, and we will engage in highly structured solutions for those companies. In that same theme of non sponsor lending, our activity in the Life Sciences area continues to be robust. We were very active last year in Life Sciences.
We have a few deals that we're considering right now in the pipeline that are very attractive, consistent with our prior structures and return expectations. And we expect we'll continue to do that. So I know that I kind of went around the world a little bit there on the market color. But we feel pretty good that we will be able to transition the OCSI portfolio over a few quarters. It's not going to be over 1 quarter to an OCSL type portfolio, well within the 1 or 2 years that we've contemplated it will take, just given the strength of our pipeline, especially in the non sponsor area.
And it helps that so much of the non overlapping positions are publicly traded securities that frankly are trading quite well during the current under the current market circumstances.
Okay. That's terrific color. Thanks, Armand. And then maybe just a follow-up here. This one might be difficult, but you've had 3 consecutive quarters of increasing the dividend, which is great.
I'm not sure if you can maybe just help us think about the outlook for the rest of 2021 and the trajectory. And if you can't give kind of specifics, what should investors be looking for in order to think about kind of the dividend continuing to trend higher from here?
Yes. Thanks for the question. We really want to not provide forward looking guidance on things like dividends or earnings. We feel really good about the portfolio, the income it's generating and our pipeline, but to make predictions, I think, forward looking is something that we're just not comfortable doing right now, fortunately.
Yes. I think it's Matt. The other thing, Devin, just that we're thoughtful and we have as you pointed out, we raised the dividend in the last three quarters. We've also had in the September quarter, we had a large kind of one time item through the new stock payment, which flowed through investment income. This past quarter, we had Avan that again also flowed through investment income.
So we want to be mindful of those one time items. If you take those out and just look at our investment performance going back to a year ago, it was $0.10 a year ago, it was $0.122 in the September quarter and $0.124 in this quarter. So looking at kind of that underlying kind of quarter in quarter end kind of recurring portfolio and income is if you were to look at one thing, that's kind of what we're very focused on as the Board thinks about the dividend.
Yes. Okay, very helpful. I'll leave it there. Thank you guys. Appreciate it.
Thank you.
The next question comes from Kyle Joseph of Jefferies. Please go ahead.
Hey, good morning. Thanks for taking my questions. Congratulations on another strong quarter. Let's start on your net interest margin, if you don't mind. Just give us a sense for on the yield side of things, obviously, it sounds like spreads have tightened, but there's still some ongoing portfolio rotation opportunities.
So give us a sense for how you've seen the portfolio yield trending. Obviously, it's been trending in the right direction. And then on the cost of fund side, are we kind of at the bottom here? Are there any opportunities to reduce that and give us a sense for both of those and we can figure out the margins?
I'll go first. I think on the liability side, we've got obviously the unsecured notes, the comp on that, And then we have the revolver. We've increased we've got some really strong support from our banking group and decreased the size of that over the last two quarters and obviously have a lot of capacity there. So the next dollar that we need to borrow, we would borrow from the revolver, which is LIBOR plus 200. So I think that's pretty solid.
On the asset side, the last quarter the yield was 8.7%. You saw the yield on the assets rolled off was obviously lower than that. So we don't to Armin's point, I don't want to kind of predict what the asset yield is going to be each quarter and what's going to roll off. But if you look what we did last quarter and you look at the other besides drawing the revolver, the other place we'd go to fund assets would be the seller low yielding assets and you'll just pick up the spread on the assets. So if something comes off at LIBOR plus 500, 400 and goes on at $11,000,000 $600,000 There's that spread.
It's just hard to predict each quarter what's going to be refinanced. We've seen more the end of last quarter and so far this quarter, there's been more refinancing activities as the market has been robust. So it's just hard to predict that because a quarter ago we weren't seeing that in that ebb and flow. But I think that gives you a sense kind of what we're trying to do on the asset side in terms of new originations, on the asset side in terms of selling the lower yielding assets, and then on the liability side.
Yes. And
if you look at our origination in the last couple of quarters, I mean that's consistent with where we would like to continue to originate. So it's not like we are looking to go tighter than that and we're certainly not looking to take equity like risk in anything we originate. So that's really the origination you're seeing from us is kind of where our intention is going forward. And we do have maybe just look at our positions and we do have a significant enough portfolio in OCSL that is yield that has a coupon of LIBOR plus $4.50 or lower that can be rotated. Now it's predicated on the pace of our repayments as well on positions that we would ordinarily have liked to have kept, but just given with market strength, those are being, to some extent, taken from us.
But we are we certainly have a targeted portfolio that we would like to exit and rotate into higher yielding instruments consistent with our last few quarters of origination.
Got it. Very helpful. Thanks. And then I'd like to ask one on credit. Obviously, it's been very solid and way better than we would have initially expected last spring.
But can you give us a sense for kind of amendment activity trends you're seeing? I know you mentioned that only one investment had moved to pick. And then just give us a sense for revenue and EBITDA growth or performance in the Q4 and how that compared to the Q3 for the portfolio broadly?
Sure. This is Armin. So, yes, on the amendment side, it's been very quiet. We continue to only have one name on non accrual and one name that is subject to an amendment or a pick. We have not been contacted and are not engaged with any other kind of material issues in the portfolio around poor performance.
So we feel really good about that. I don't expect for us to have a meaningful uptick in defaults based on the information at hand today. In terms of performance of the underlying companies, it's hard to generalize, but I would say that those industries that are most sensitive to COVID, and I would we do have some exposure there. We have some entertainment related businesses that are focused on live events. We have some leisure oriented positions.
I mean, these are not very large positions in the portfolio, but we do have some. Those two areas as well as some of the airline oriented and aerospace and defense oriented businesses that we have are the most impacted from a top line perspective. Obviously, businesses with exposure to live events are at very little to no revenue and they're in cost cutting mode, cash flow preservation mode. In the instances where we have exposure there, the companies are sitting on a lot of cash and have very strong sponsor protection. And in several of those situations not that there are so many situations, but in most of them, there are recent buyouts by sponsors.
And the when we did reach out to those sponsors over the course of the last 12 months, the response was, we'll let you know if we need incremental liquidity. We don't think we will. We think we can manage the cash. And by the way, there's no way we're letting this go. So don't think that you have a distressed opportunity on your hands.
So it's been very positive. Now those businesses, the most directly impacted, their revenues could be down as much as 70% or 80% year over year. More typical is down 30% or 40% year over year in these very deeply impacted sectors. But away from the most COVID sensitive names, the revenues, especially in the last couple of quarters, have been flat to slightly up year over year. And in some cases, there are businesses that we've invested in that have benefited from COVID, including fast food restaurants, including the life sciences businesses that have been nice surprises to the upside, the technology oriented businesses that provide cloud computing related services are doing quite well as one might imagine.
We've been involved with a few recent tech LBOs in the last couple of quarters around that are that provide services for remote computing. They've been doing really well. So again, it's kind of all over the place. And thankfully, we just don't have very much exposure that is deeply exposed to COVID. And where we do have that exposure, the companies either have the ability to cut costs essentially to the bone or they have a very strong sponsor standing behind them and willing to put in money if
needed. Got it. Very helpful. Thanks a lot for answering my questions.
No problem. Thank you.
The next question comes from Finian O'Shea of Wells Fargo Securities. Please go ahead.
Hi, everyone. Good morning. Just a first question on OCSI for those of us who are a little less familiar. You put the GLIC JV onto non accrual due to COVID volatility. That's obviously a big investment that weighs a bit on portfolio yields.
Are you able to update us on how you think about that on being non accrual that is?
Sure. We've worked on non accrual this last quarter as well. And as you noted, it is related to COVID related volatility or sensitivity. The assets in the GLIC JV have appreciated in value fairly considerably over the last few quarters. And so we will consider bringing back that position on off of non accrual every quarter.
We will always consider that. We didn't feel comfortable doing it this quarter. We will reevaluate next quarter. I don't want to provide forward looking guidance, but we're happy about the performance of the underlying assets, both in terms of lack of default experience, but also in terms of market price appreciation.
I'll also add, Fin, that although we are not accruing interest on the JV, it is generating positive net investment income. And we're using that to pay down the subordinated notes and grow NAV there. So that is a benefit to shareholders.
Yes. Very well.
Thank you.
Art, the note that we have on the GLP JV is actually marked higher today as of twelvethirty one versus twelvethirty onetwenty 19. So just to give you a sense of our perception or our feeling around that position.
Okay. And then on one of your legacy names in OCSL, Dominion Diagnostics, that has been pulling on the revolver, it looks like a little more this quarter. Are you able to give us any color on what's behind that?
Sure. So Dominion actually is a beneficiary of the pandemic. They are pretty actively involved with COVID testing. The company is actually performing as a result of that better than what we'd have expected. It's certainly its core business is certainly still suffering, but it's doing better than what we would have thought.
I would need to get back to you on the details, but I around the revolver in particular, but I know that the business has needed to staff up as well as buy working capital in support of this COVID testing business.
Okay. Thank you. And just a small final question. Obviously, a very good quarter for you guys on NOI and NAV. Just on Edmentum being exited, I assume there was some top line income that you received that's been on non accrual for a while.
Was that is that correct for one? And was that material impact to your top line, the Amentum income that you may have realized this quarter?
I'll ask Mel or Matt to answer that question. I'm not sure.
Sure. In terms of Admintum, the majority of income generated there was below the line as realized gain. As I mentioned in my prepared remarks, it was about 23,000,000
dollars Okay. Thanks so much.
It wasn't a lot in investment income.
Yes. It was immaterial. It's not like we can go back and recognize interest income that during the time it was on non accrual. So we have recognized a small amount in the current quarter, but the majority was realized gain.
The next question comes from Melissa Wedel of JPMorgan. Please go ahead.
Good morning. I wanted to touch base quickly on some of the new deployments this quarter and comparing that to sort of the levels and yields from last quarter. I want to make sure I'm thinking about this right, but your slide deck was showing about $240,000,000 deployed this quarter at an average yield of 8.7% versus 146% last quarter at 10.6%. So can you provide some context around that? And if there's anything sort of missing from that number that we should be factoring in?
Yes. Thanks for the question. So the quarter ended September 30, obviously, began July 1. And during those summer months, the activity around rescue loans in particular was higher than what it was in the following quarter for the quarter ended twelvethirty one and frankly what we're seeing today in the market. So we were our yields were highly or the yields on our new investments, new originations were highly correlated with that rescue lending opportunity.
When as that opportunity has subsided, we are dealing with issuers that are far less desperate and have potentially other options as those opportunistic lenders and middle market direct lenders that were fairly frozen in the 2nd calendar quarter, they started coming back towards the mid to late part of the calendar Q3, the quarter ended September 30. So the rescue lending, it's really the rescue lending part of the business that was driving those double digit type yields. And as that has declined, so has our average yield into earned originations. And we also just there was one position that we originated in the month of August, it might have gotten funded early September. That was a 14% loan to a single borrower and it was and it's a decent size.
It's the new ag transaction. It probably skewed that quarter a little bit because of that one transaction. And those we continue to look for those types of deals. That is not a rescue loan actually. That is just a highly structured and frankly pretty interesting loan.
Will always look for these non sponsored transactions, but this is just evidence that, that part of our business can be quite lumpy. We might have a quarter where we do very little in the non sponsored area that we might have a quarter like the quarter ended September 30, where we have a new ag or a new star or something like that. But really, 1 or 2 deals might massively skew the average.
Okay, understood. That's really helpful. I guess as a follow-up on that, do you see have much visibility into sort of a repayment pipeline? Anything big you're expecting?
Yes. I can't put numbers on it. But if you follow the broadly syndicated loan market, that is a pretty good indication for what we expect to see in the middle market landscape as well potentially on a lag basis. In the broadly syndicated loan market, the best 90% of that market. So if you exclude the bottom 10% because of default risk or just trading low for idiosyncratic reasons, that best 90% is trading pretty close to par or even above par at this point.
And it's resulted in the month of January in a significant repricing wave in the broadly syndicated loan market. And in fact, we have seen a couple of second lien positions that we recently clubbed up and took on in 2020 get repaid through the upsizing of a broadly syndicated 1st lien. And so they upsize the 1st lien and take out the entirety of the 2nd lien to reduce their cost of debt. It's hard for me to predict the volume of that impact on a go forward basis. But the market color that I would give you today is that especially in the month of January, it's become quite active.
And it's not surprising, given the fact that there's been so many inflows, retail inflows into broadly syndicated loan funds as well as CLO creation, that has driven those prices, prices higher. And the broad one last data point for you. On the broadly syndicated loan market, the index was up about 135 basis points in the month of January alone. So that's a very, very big month and it's driven by the technicals there. I expect that given that technical and given such a strong fundraising year in 2020, but also in the last few quarters, just middle market direct lending funds have been very actively fundraising.
I would suspect that there would be an increase in repayment activity in the more flow oriented LDO backed part of the market. That's just the part of the market that's very heavily trafficked. And the call protection is not material. It's typically only about a year and then some elevated call premium. So I would expect some repayment activity to pick up even in the middle market over the next couple of quarters if these current market technicals persist.
Okay, great. Thanks so much.
We have no further questions. Mr. Mosticchio?
Great. Thanks, Andrea, and thank you all for joining us on today's earnings conference call. A replay of this call will be available for 30 days on OCSL's website in the Investors section or by dialing 877-344-7529 for U. S. Callers or 1-four twelve-three seventeen-eighty eight for non U.
S. Callers with the replay access code 10,150,000 and 69 beginning approximately 1 hour after this broadcast.